Cambridge Investment Research Advisors
CALC icon

Cambridge Investment Research Advisors’s CalciMedica CALC Stock Holding History

Cambridge Investment Research Advisors’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62K Hold
12,000
– – ﹤0.01% 3968
2026
Q1 		$32K Buy
+12,000
New +$122K ﹤0.01% 3877
2025
Q2 		– Sell
-4,708
Closed -$45K – 3639
2025
Q1 		$45K Buy
+4,708
New +$58.7K ﹤0.01% 3414

Other funds holding CALC

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
LGM
L1 Global Manager Melbourne $142M AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Cambridge Investment Research Advisors's CALC Position: Q2 2026 in Review

Cambridge Investment Research Advisors held its CalciMedica (CALC) position steady in Q2 2026 at 12,000 shares worth $62K. The position accounts for ﹤0.01% of the portfolio, ranked #3968.

Cambridge Investment Research Advisors first reported a position in CALC in Q1 2025 and has held it in 3 quarters since. 31 funds tracked by Wall St. Rank hold CALC as of Q2 2026.

  • Cambridge Investment Research Advisors held 12,000 shares of CalciMedica worth $62K as of Q2 2026.
  • Cambridge Investment Research Advisors left its CalciMedica share count unchanged in Q2 2026.
  • CalciMedica made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3968 holding.
  • Cambridge Investment Research Advisors first reported a position in CalciMedica in Q1 2025 and has held it in 3 quarters since.
  • 31 funds tracked by Wall St. Rank held CalciMedica as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.